11/07/2024 12:15 PM | Athira Pharma (Subject) BML Investment Partners, L.P. (Filed by)
| Form SC 13G | |
10/31/2024 3:16 PM | Athira Pharma (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
10/28/2024 11:15 PM | Athira Pharma (Filer)
| Form EFFECT | |
10/21/2024 5:24 AM | Athira Pharma (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
10/03/2024 8:50 PM | Athira Pharma (Issuer) Litton Mark James (Reporting)
| Form 4/A | |
10/03/2024 6:07 PM | Athira Pharma (Issuer) Litton Mark James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 6:08 PM | Athira Pharma (Issuer) Worthington Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
10/03/2024 6:10 PM | Athira Pharma (Issuer) CHURCH KEVIN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 6:13 PM | Athira Pharma (Issuer) San Martin Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 6:17 PM | Athira Pharma (Issuer) Renninger Robert (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 6:05 PM | Athira Pharma (Issuer) Renninger Robert (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/17/2024 8:00 AM | Athira Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2024 6:47 PM | Athira Pharma (Issuer) Litton Mark James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 6:48 PM | Athira Pharma (Issuer) Worthington Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 6:49 PM | Athira Pharma (Issuer) CHURCH KEVIN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 6:50 PM | Athira Pharma (Issuer) Lenington Rachel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 6:51 PM | Athira Pharma (Issuer) Gengos Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 6:53 PM | Athira Pharma (Subject) Litton Mark James (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024 3:15 PM | Athira Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/25/2024 6:21 PM | Athira Pharma (Issuer) Romano Kelly A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 3:05 PM | Athira Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/24/2024 5:54 PM | Athira Pharma (Issuer) FLUKE JOHN M JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 5:55 PM | Athira Pharma (Issuer) PICKERING GRANT (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 5:56 PM | Athira Pharma (Issuer) Panzara Michael A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 5:58 PM | Athira Pharma (Issuer) Kosacz Barbara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 6:00 PM | Athira Pharma (Issuer) JOHNSON JAMES A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 6:01 PM | Athira Pharma (Issuer) EDELMAN JOSEPH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 6:03 PM | Athira Pharma (Issuer) Romano Kelly A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2024 3:34 PM | Athira Pharma (Issuer) San Martin Javier (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/16/2024 3:37 PM | Athira Pharma (Issuer) San Martin Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2024 7:32 AM | Athira Pharma (Filer)
| Form DEF 14A | |
04/09/2024 7:34 AM | Athira Pharma (Filer)
| Form DEFA14A | |
04/09/2024 7:35 AM | Athira Pharma (Filer)
| Form ARS | |
03/28/2024 7:47 AM | Athira Pharma (Filer)
| Form PRE 14A | |
02/22/2024 3:34 PM | Athira Pharma (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/22/2024 3:15 PM | Athira Pharma (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/16/2024 3:46 PM | Athira Pharma (Issuer) Lenington Rachel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:48 PM | Athira Pharma (Issuer) Gengos Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:54 PM | Athira Pharma (Issuer) CHURCH KEVIN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:32 PM | Athira Pharma (Issuer) CHURCH KEVIN (Reporting)
| Form 4/A | |
02/16/2024 3:34 PM | Athira Pharma (Issuer) Gengos Andrew (Reporting)
| Form 4/A | |
Download Our Tesla Ebook For Free (Ad) Like many of you, we here at the TradingPub are bullish on Tesla long term.
We believe the company will continue to be a leader in technology, EVs and A.I.
We also believe it’s share price will be rewarded in a big way…
In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost. To claim your copy free of charge simply follow this link. |
02/16/2024 3:37 PM | Athira Pharma (Issuer) Worthington Mark (Reporting)
| Form 4/A | |
02/16/2024 3:38 PM | Athira Pharma (Issuer) Litton Mark James (Reporting)
| Form 4/A | |
02/16/2024 3:40 PM | Athira Pharma (Issuer) Lenington Rachel (Reporting)
| Form 4/A | |
01/08/2024 3:36 PM | Athira Pharma (Issuer) CHURCH KEVIN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:38 PM | Athira Pharma (Issuer) Worthington Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:40 PM | Athira Pharma (Issuer) Litton Mark James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:42 PM | Athira Pharma (Issuer) Gengos Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:45 PM | Athira Pharma (Issuer) MOEBIUS HANS (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:35 PM | Athira Pharma (Issuer) Lenington Rachel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 6:11 AM | Athira Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/29/2023 4:24 PM | Athira Pharma (Issuer) EDELMAN JOSEPH (Reporting) PERCEPTIVE ADVISORS LLC (Reporting) PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 4:15 PM | Athira Pharma (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |